Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial (Q30276649)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial |
scientific article |
Statements
1 reference
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial (English)
1 reference
Craig L Slingluff
1 reference
F Stephen Hodi
1 reference
Elizabeth I Buchbinder
1 reference
Jeffrey S Weber
1 reference
Geoff Gibney
1 reference
Ryan J Sullivan
1 reference
Jeffrey A Sosman
1 reference
Donald P Lawrence
1 reference
Theodore F Logan
1 reference
Lynn M Schuchter
1 reference
Suresh Nair
1 reference
Leslie Fecher
1 reference
Elmer Berghorn
1 reference
Mary Ruisi
1 reference
George Kong
1 reference
Joel Jiang
1 reference
Christine Horak
1 reference
1 reference
2 references
Identifiers
1 reference